Profissionais: 7088
Prontuários: 488795

Portal Saúde Direta - Busca Palavra




Protocolos Algoritmos Diretrizes Fluxogramas

Advertência: Estes artigos e resumos são protegidos pela Lei de Direitos Autorais (Lei 9.610/98), sendo vedada a sua transcrição sem citação da fonte e a sua reprodução com finalidades comerciais sem autorização dos autores.

Adobe Acrobat Reader
É necessário o Adobe Acrobat Reader instalado.

Manual para Prevenção das Infecções Hospitalares

Cassettari, Valéria Chiaratto; Balsamo, Ana Cristina; Silveira, Isa Rodrigues
Hospital Universitário da Universidade de São Paulo, São Paulo, 2009
Número: 2916 / Publicado em 18/06/2016 - 10:47

O objetivo deste manual é orientar os profissionais de saúde sobre as medidas básicas de prevenção das infecções hospitalares através de uma padronização clara e objetiva. Tratam-se de medidas simples, porém essenciais, sendo de execução obrigatória na rotina de um hospital. Assim, ao facilitar sua execução, este manual deve contribuir para o contínuo aprimoramento do atendimento hospitalar.

Abrir arquivo em PDF

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update

Peter G. Pappas, Carol A. Kauffman, David R. Andes, Cornelius J. Clancy, Kieren A. Marr, Luis Ostrosky-Zeichner, Annette C. Reboli, Mindy G. Schuster, Jose A. Vazquez, Thomas J. Walsh, Theoklis E. Zaoutis, and Jack D. Sobel
Infectious Diseases Society of America
Número: 2915 / Publicado em 25/02/2016 - 08:49

Invasive infection due to Candida species is largely a condition associated with medical progress, and is widely recognized as a major cause of morbidity and mortality in the healthcare environment. There are at least 15 distinct Candida species that cause human disease, but >90% of invasive disease is caused by the 5 most common pathogens, C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, and C. krusei.

Abrir arquivo em PDF

Sexually Transmitted Diseases Treatment Guidelines, 2010

Centers for Disease Control and Prevention
U.S. Department of Health and Human Services, Atlanta, GA
Número: 2914 / Publicado em 15/01/2016 - 17:08

Included in these updated guidelines is new information regarding 1) the expanded diagnostic evaluation for cervicitis and trichomoniasis; 2) new treatment recommendations for bacterial vaginosis and genital warts; 3) the clinical efficacy of azithromycin for chlamydial infections in pregnancy; 4) the role of Mycoplasma genitalium and trichomoniasis in urethritis/cervicitis and treatment-related implications; 5) lymphogranuloma venereum proctocolitis among men who have sex with men; 6) the criteria for spinal fluid examination to evaluate for neurosyphilis; 7) the emergence of azithromycin-resistant Treponema pallidum; 8) the increasing prevalence of antimicrobial-resistant Neisseria gonorrhoeae; 9) the sexual transmission of hepatitis C; 10) diagnostic evaluation after sexual assault; and 11) STD prevention approaches.

Abrir arquivo em PDF

Interventions for Alopecia Areata

Delamere Finola M, Sladden Michael J, Dobbins Helen M, Leonardi Bee Jo
Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 7, Art. No. CD004413
Número: 2913 / Publicado em 10/01/2016 - 13:24

Alopecia areata is a disorder in which there is loss of hair causing patches of baldness but with no scarring of the affected area. It can affect the entire scalp (alopecia totalis) or cause loss of all body hair (alopecia universalis). It is a relatively common condition affecting 0.15% of the population. Although in many cases it can be a selflimiting condition, nevertheless hair loss can often have a severe social and emotional impact.

Abrir arquivo em PDF

British Association of Dermatologists’ guidelines for the management of alopecia areata 2012

A.G. Messenger, J. McKillop, P. Farrant, A.J. McDonagh and M. Sladden
British Association of Dermatologists 2012 166, pp916–926
Número: 2912 / Publicado em 18/10/2015 - 21:54

This document has been prepared on behalf of the BAD and is based on the best data available when the document was prepared. It is recognized that under certain conditions it may be necessary to deviate from the guidelines, and that the results of future studies may require some of the recommendations herein to be changed. Failure to adhere to these guidelines should not necessarily be considered negligent, nor should adherence to these recommendations constitute a defence against a claim of negligence.

Abrir arquivo em PDF

Evidence Check 2: Homeopathy

Fourth Report of Session 2009–10
House of Commons: Science and Technology Committee
Número: 2911 / Publicado em 21/05/2015 - 14:49

We proceed on the basis that homeopathy is not supported by evidence of efficacy and is therefore no more than a placebo treatment, albeit a popular one. But before we discuss government policy in relation to the evidence, it is important to consider what evidence there is on the effectiveness of homeopathy.

Abrir arquivo em PDF

ADAPTE Process: Resource Toolkit for Guideline Adaptation

The ADAPTE Collaboration (2009)
Guideline International Network (
Número: 2910 / Publicado em 12/05/2015 - 13:02

The development and updating of high-quality practice guidelines require substantial resources, and most organisations are under pressure to produce more guidelines in a shorter time with increasingly limited resources. In order to take advantage of existing guidelines and reduce the duplication of effort, guideline adaptation has been proposed as an option for guideline development.

Abrir arquivo em PDF

Appraisal of Guidelines for REsearch & Evaluation (AGREE)

The AGREE Research Trust, September 2013.
Número: 2909 / Publicado em 05/04/2015 - 11:31

The Appraisal of Guidelines for Research & Evaluation(AGREE) instrument was developed to address the issue of variability in guideline quality. To that end, the AGREE instrument is a tool that assesses the methodological rigour and transparency in which a guideline is developed. The original AGREE instrument has been refined, which has resulted in the new AGREE II and includes a new User’s Manual.

Abrir arquivo em PDF

Guideline of Guidelines: Prostate Cancer Screening

Stacy Loeb
BJU Int 2014; 114: 323–325
Número: 2908 / Publicado em 06/03/2015 - 16:30

Prostate cancer screening is one of the most controversial topics in urology. On one hand, there is randomised data showing that PSA screening results in earlier stages at diagnosis, improved oncological outcomes after treatment, and lower prostate cancer mortality rates. However, the downsides include unnecessary biopsies due to false-positive PSA tests,over-diagnosis of some insignificant cancers, and potential side-effects from prostate biopsy and/or prostate cancer treatment. The ongoing controversy is highlighted by the divergent recommendations on screening from multiple professional organisations. The purpose of this article is to summarise the recent guidelines on prostate cancer screening from 2012 to present.

Abrir arquivo em PDF

Retinoids and Pregnancy: an Update

Browne H, Mason G, Tang T.
The Obstetrician & Gynaecologist 2014;16:7–11.
Número: 2907 / Publicado em 06/03/2015 - 16:17

Retinoids are widely used to treat acne, and are known to be teratogenic. When prescribed in women of childbearing age, a pregnancy prevention programme is implemented. This aims to prevent pregnancy during treatment and for at least one month following cessation. Despite these measures, pregnancy still occurs and patients often find it difficult to decide whether to continue with their pregnancy or to pursue a termination.This is compounded by a lack of literature advising professionals on how to counsel these women appropriately and approach their subsequent antenatal care. This article aims to update readers on retinoids, their use and teratogenic effects. It outlines the pregnancy prevention programme and current ways to advise and care for women in which this fails.

Abrir arquivo em PDF

Portal Saúde Direta - Footer
Atualizado em
Saude-Direta-Facebook Saude-Direta-LinkedIN Saude-Direta-Twitter